Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicines For Europe Continues To Rally For Security Of Supply

Organization Has Expressed Support For Non-Paper By 21 EU Member States

Executive Summary

Medicines for Europe has expressed its support for a non-paper already adhered to by 21 EU member states, which proposes a number of solutions which could improve security of supply for medicines in the region.

You may also be interested in...



Denmark: Critical Medicines List To Make Supply Shortage Notifications Easier

The Danish drug regulator says its new critical medicines list and notification form will make it easier for companies to notify the agency of supply shortages.

French Govt Announces List Of ‘Critical Medicines’ Amid Growing Shortage Problem

A priority list is one of the “urgent” measures the French pharma industry has called for as part of its contribution to the government’s 2023-25 roadmap for dealing with drug shortages, which is due to be published next month.

European Industry Voices Concern As Products Vanish From Market

A fresh report has offered stark new data on the extent to which generics are disappearing from the European market. Industry association Medicines for Europe has pointed to the risks of supply consolidation, urging both national- and EU-level action.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB152789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel